Biotechnology Market Research Reports | BCC Research
loading animation for AJAX calls
Items per page:   25 | 50 | 75 | 100

189 Reports in Biotechnology

Switching to CRISPR–Cas Systems from Uncultivated Microbes

Published - Sep 2018 | Analyst - Mike (Ke Ke) Fan| Code - BIO172A

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.

Current Research & Developments Status of Chimeric Antigen Recept...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO162A

The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.

Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO171A

Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...

Published - Aug 2018 | Analyst - Todd Graham| Code - BIO157A

The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.

Microbial Products: Technologies, Applications and Global Markets

Published - Aug 2018 | Analyst - Andrew McWilliams| Code - BIO086D

The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Analyst - Vijay Laxmi| Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Aug 2018 | Analyst - BCC Research Staff| Code - BIO014K

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Synthetic Biology: Global Markets

Published - Jul 2018 | Analyst - John Bergin| Code - BIO066E

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Cardiac Biomarkers: Technologies and Global Markets

Published - Jul 2018 | Analyst - Paul Taylor| Code - BIO128C

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Digital Polymerase Chain Reaction (PCR) Technology: Global Market...

Published - Jun 2018 | Analyst - Todd Graham| Code - BIO137B

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Analyst - Marianna Tcherpakov| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

The Chinese Market for DNA Sequencing

Published - Jun 2018 | Analyst - Jason Chen| Code - BIO152B

The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.

Biosimilars: Global Markets

Published - Apr 2018 | Analyst - Kamna Jhamb| Code - BIO090C

The global biosimilars market reached nearly $5.5 billion in 2017 and is expected to reach $20.8 billion by 2022, with a compound annual growth rate (CAGR) of 30.5% from 2017 through 2022.

Artificial Blood: Global Markets to 2027

Published - Apr 2018 | Analyst - BCC Research Staff| Code - BIO164A

The global market for potential artificial blood is estimated to grow from nearly $6.2 billion in 2022 to $15.6 billion by 2027 with a compound annual growth rate (CAGR) of 20.5% for the period of 2022-2027.

Cell Therapy Processing: Global Markets and Technologies

Published - Apr 2018 | Analyst - Sangeeta Rai| Code - BIO160A

The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.

The Global Market for Stem Cells

Published - Apr 2018 | Analyst - Paul Evers| Code - BIO035G

The global market for stem cells totaled $7.4 billion in 2017 and is estimated to reach $14.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 14.7% for the period of 2017-2022.

Biologics Development and Manufacturing Testing: Technologies and...

Published - Mar 2018 | Analyst - David Peters| Code - BIO155A

The global biological safety testing market should reach $13.1 billion by 2022 from $5.1 billion in 2017 at a compound annual growth rate (CAGR) of 20.9%, from 2017 to 2022.

Mobile Apps for DNA Sequencing: Global Markets

Published - Mar 2018 | Analyst - Smruti Munshi| Code - BIO156A

The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.

Drug Discovery Technologies

Published - Feb 2018 | Analyst - Shalini Shahani Dewan| Code - BIO020F

The global market for drug discovery technologies totaled $54.7 billion in 2017. The market should reach $85.8 billion by 2022, growing at a compound annual growth rate (CAGR) of 9.4% during 2017-2022.

Global Markets for Research Antibodies

Published - Jan 2018 | Analyst - Mike (Ke Ke) Fan| Code - BIO141B

The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.

Single-cell Omics: Emerging Technologies and Markets

Published - Jan 2018 | Analyst - John Bergin| Code - BIO143B

The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.

Cancer Stem Cells: Technologies and Global Markets

Published - Jan 2018 | Analyst - Sangeeta Rai| Code - BIO158A

The global market for cancer stem cells will grow from $745 million in 2017 to $1.9 billion by 2022 with a compound annual growth rate (CAGR) of 21.2% for the period of 2017-2022.

Global Markets for Enzyme Inhibitors

Published - Jan 2018 | Analyst - Shalini Shahani Dewan| Code - BIO057C

The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.

Botanical and Plant-derived Drugs: Global Markets

Published - Dec 2017 | Analyst - Kim Lawson| Code - BIO022H

The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.

Commercial Amino Acids

Published - Nov 2017 | Analyst - Jon Evans| Code - BIO007L

The U.S. amino acid market was valued at around $1.9 billion in 2016. This market will grow from nearly $2.0 billion in 2017 to $2.5 billion by 2022 with a compound annual growth rate (CAGR) of 4.8% for the period of 2017-2022.

23 Upcoming Reports in Biotechnology

Biomarkers: Technologies and Global Markets

Target Date - Aug 2018| Author - BCC Research Staff| Code - BIO061E| Price - $5,500

Report Includes

  • Industry analysis of the global biomarkers market within the industry
  • Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, Middle East and Africa
  • Breakdown of the global biomarkers market by segments such as product type, application sector, end user and geographical region
  • Exploration of regional market dynamics with a focus on regulatory development, key technology update and major drivers impacting the global market
  • Market assessment of the companies poised to introduce products during the forecast period and how these introduces will change the face of the competitive environment
  • Detailed profiles of the major market players within the biotechnology industry

Notify Me

Immunoassays: Technologies and Global Markets

Target Date - Aug 2018| Author - BCC Research Staff| Code - BIO033C| Price - $5,500

Report Includes

  • Country specific data and analysis for United States, Mexico, Canada, UK, China and India
  • Information about in vitro diagnostics (IVD), its background and importance of IVD testing
  • Discussion about prevalence of infectious disease, metabolic disorders and chronic ailments as a drivers of immunoassay testing
  • A look into the current industry trends and dynamics within the immunoassay market’
  • Description about recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays and rapid diagnostic technologies
  • Detailed analysis of the key competitor engaged in the immunoassay market, including F. Hoffmann-La Roche Ltd, Abbott Laboratories, Ortho Clinical Diagnostics, Siemens Healthcare Gmbh ,Biomérieux Sa And Danaher Corp

Notify Me

Global Markets for Enzymes in Industrial Applications

Target Date - Aug 2018| Author - BCC Research Staff| Code - BIO030K| Price - $5,500

Report Includes

  • An overview of the global markets for enzymes in industrial applications
  • Analyses of global market trends, with data from 2017, 2018, and projections of CAGRs through 2023
  • Coverage of definition of enzymes, historical background of industrial enzymes, enzyme nomenclature and classification
  • Insight into enzyme market including detergent enzymes, technical enzymes, food enzymes, and animal-feed enzymes.
  • Discussion about technological issues, latest trends, pipeline products, and developments
  • Analyses of the key market players including, Novozymes, BASF Corp., Associated British Foods plc (AB Enzymes), Danisco/DuPont (Genencor Industrial Biosciences), Specialty Enzymes and Biotechnology Ltd., DSM, Maps Enzymes Ltd., and Chr. Hansen /A/S

Notify Me

Next Generation Sequencing for Non-invasive Prenatal Testing: Global Insights

Target Date - Aug 2018| Author - BCC Research Staff| Code - BIO173A| Price - $5,500

Report Includes

  • An overview of the global insights of next generation sequencing (NGS) for non-invasive prenatal testing (NIPT) within the biotechnology industry
  • Country specific data and analysis for United States, France, Germany, U.K., Italy, Spain, China, India, Japan, South Korea and rest of the world countries
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Characterization and quantification of the market potential for NGS by geographical region, type, application sector, and end user industry
  • Discussion of next generation sequencers, NGS technologies, NIPT methods, clinical applications and industry structure
  • Examination of regional dynamics, and key technological updates for both NGS and NIPT market
  • Comprehensive profiles of the leading companies involved in the clinical, genetic testing and sequencing industries

Notify Me

Protein Analysis: Subfocus on Oncoproteomics

Target Date - Sep 2018| Author - Anuj Pathak| Code - BIO168A| Price - $5,500

Report Includes

  • An overview of the global market for protein analysis and oncoproteomics
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Insight into regulatory aspects, current and developing technologies, market projections and market shares of the industry
  • Discussion about patents analysis, clinical trials, innovations and opportunities
  • Evaluation of present and future strategies influencing the Protein analysis market
  • Analysis of the company profiles of the industry including, Bio-Red Laboratories Inc, Epicypher, Glaxosmithkline, Imtakt Corp, MRM Protein Analysis, and Quansys Biosciences

Notify Me

Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing

Target Date - Sep 2018| Author - John Bergin| Code - BIO159A| Price - $5,500

Report Includes

  • An overview of the global market for genetic modification therapies.
  • Analyses of global market trends, with data from 2016, 2017 and projections of compound annual growth rates (CAGRs) through 2022.
  • Market breakdown by indication, technology, delivery platform, and by region.
  • An overview of the genetic variation analysis and genetic modification technologies.
  • Key growth driving forces, acquisitions and strategic alliances related to the market.
  • Detailed description of the criteria for selecting gene modification therapy applications.
  • Review of patents for gene editing, gene therapy, RNA therapy and gene modification therapies.
  • Profiles of the key companies in the market.

Notify Me

Proteomics: Technologies and Global Markets

Target Date - Sep 2018| Author - Bhavna Joshi| Code - BIO034E| Price - $5,500

Report Includes

  • An overview of the global proteomics market, which covers: technologies, platform and software markets, disease markets, biochip markets and end-use industry markets
  • Analyses of global market trends, with data from 2016 and 2017, and projections of CAGRs through 2022
  • Examination of market trends and opportunities that will impact the future market
  • A look at proteomics scientific initiatives, industry acquisitions and patents
  • Discussion of proteomic applications in drug discovery and development
  • Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM